Hosted on MSN
DGX Q2 Deep Dive: Acquisitions, Advanced Diagnostics, and Utilization Trends Drive Growth
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q2 CY2025 results , with sales up 15.2% year on year to $2.76 billion. The company’s full-year revenue guidance of $10.86 billion ...
CEO Jim Davis reported a nearly 15% revenue growth for Q4, including 5% organic growth, and close to 7% revenue growth for the full year, supported by eight acquisitions. He highlighted the Advanced ...
Quest Diagnostics DGX is set to release its second-quarter 2025 results on July 22, before the market opens. The renowned diagnostics provider posted adjusted earnings per share (EPS) of $2.21 in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback